A world leader in the discovery and development of innovative therapeutic products for the treatment of neurological disorders involving Neural Stress Response
Ester Neurosciences was established in 1997 by Medica Venture Partners to commercialize breakthrough discoveries pioneered by the Company's Chief Scientific Advisor, Prof. Hermona Soreq of the Hebrew University in Jerusalem, Israel. Ester Neurosciences is focused on developing therapeutic drugs to treat neurological related diseases. Ester's mission is to become a world leader in the discovery and development of innovative therapeutic products for the treatment of neurological disorders involving Neural Stress Response (NSR). Ester's goal and strategy are to utilize its versatile platform technology to develop a range of products, which will be commercially promoted by implementing a unique business model and creating strategic alliances with large pharmaceutical companies.